6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      2021 Guideline for the Management of COPD Exacerbations: Emergency Medicine Association of Turkey (EMAT) / Turkish Thoracic Society (TTS) Clinical Practice Guideline Task Force

      other

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Chronic obstructive pulmonary disease (COPD) is an important public health problem that manifests with exacerbations and causes serious mortality and morbidity in both developed and developing countries. COPD exacerbations usually present to emergency departments, where these patients are diagnosed and treated. Therefore, the Emergency Medicine Association of Turkey and the Turkish Thoracic Society jointly wanted to implement a guideline that evaluates the management of COPD exacerbations according to the current literature and provides evidence-based recommendations. In the management of COPD exacerbations, we aim to support the decision-making process of clinicians dealing with these patients in the emergency setting.

          Related collections

          Most cited references230

          • Record: found
          • Abstract: not found
          • Article: not found

          RoB 2: a revised tool for assessing risk of bias in randomised trials

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

            Summary Background In an era of shifting global agendas and expanded emphasis on non-communicable diseases and injuries along with communicable diseases, sound evidence on trends by cause at the national level is essential. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic scientific assessment of published, publicly available, and contributed data on incidence, prevalence, and mortality for a mutually exclusive and collectively exhaustive list of diseases and injuries. Methods GBD estimates incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) due to 369 diseases and injuries, for two sexes, and for 204 countries and territories. Input data were extracted from censuses, household surveys, civil registration and vital statistics, disease registries, health service use, air pollution monitors, satellite imaging, disease notifications, and other sources. Cause-specific death rates and cause fractions were calculated using the Cause of Death Ensemble model and spatiotemporal Gaussian process regression. Cause-specific deaths were adjusted to match the total all-cause deaths calculated as part of the GBD population, fertility, and mortality estimates. Deaths were multiplied by standard life expectancy at each age to calculate YLLs. A Bayesian meta-regression modelling tool, DisMod-MR 2.1, was used to ensure consistency between incidence, prevalence, remission, excess mortality, and cause-specific mortality for most causes. Prevalence estimates were multiplied by disability weights for mutually exclusive sequelae of diseases and injuries to calculate YLDs. We considered results in the context of the Socio-demographic Index (SDI), a composite indicator of income per capita, years of schooling, and fertility rate in females younger than 25 years. Uncertainty intervals (UIs) were generated for every metric using the 25th and 975th ordered 1000 draw values of the posterior distribution. Findings Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates. After taking into account population growth and ageing, the absolute number of DALYs has remained stable. Since 2010, the pace of decline in global age-standardised DALY rates has accelerated in age groups younger than 50 years compared with the 1990–2010 time period, with the greatest annualised rate of decline occurring in the 0–9-year age group. Six infectious diseases were among the top ten causes of DALYs in children younger than 10 years in 2019: lower respiratory infections (ranked second), diarrhoeal diseases (third), malaria (fifth), meningitis (sixth), whooping cough (ninth), and sexually transmitted infections (which, in this age group, is fully accounted for by congenital syphilis; ranked tenth). In adolescents aged 10–24 years, three injury causes were among the top causes of DALYs: road injuries (ranked first), self-harm (third), and interpersonal violence (fifth). Five of the causes that were in the top ten for ages 10–24 years were also in the top ten in the 25–49-year age group: road injuries (ranked first), HIV/AIDS (second), low back pain (fourth), headache disorders (fifth), and depressive disorders (sixth). In 2019, ischaemic heart disease and stroke were the top-ranked causes of DALYs in both the 50–74-year and 75-years-and-older age groups. Since 1990, there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries. In 2019, there were 11 countries where non-communicable disease and injury YLDs constituted more than half of all disease burden. Decreases in age-standardised DALY rates have accelerated over the past decade in countries at the lower end of the SDI range, while improvements have started to stagnate or even reverse in countries with higher SDI. Interpretation As disability becomes an increasingly large component of disease burden and a larger component of health expenditure, greater research and development investment is needed to identify new, more effective intervention strategies. With a rapidly ageing global population, the demands on health services to deal with disabling outcomes, which increase with age, will require policy makers to anticipate these changes. The mix of universal and more geographically specific influences on health reinforces the need for regular reporting on population health in detail and by underlying cause to help decision makers to identify success stories of disease control to emulate, as well as opportunities to improve. Funding Bill & Melinda Gates Foundation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Rayyan—a web and mobile app for systematic reviews

              Background Synthesis of multiple randomized controlled trials (RCTs) in a systematic review can summarize the effects of individual outcomes and provide numerical answers about the effectiveness of interventions. Filtering of searches is time consuming, and no single method fulfills the principal requirements of speed with accuracy. Automation of systematic reviews is driven by a necessity to expedite the availability of current best evidence for policy and clinical decision-making. We developed Rayyan (http://rayyan.qcri.org), a free web and mobile app, that helps expedite the initial screening of abstracts and titles using a process of semi-automation while incorporating a high level of usability. For the beta testing phase, we used two published Cochrane reviews in which included studies had been selected manually. Their searches, with 1030 records and 273 records, were uploaded to Rayyan. Different features of Rayyan were tested using these two reviews. We also conducted a survey of Rayyan’s users and collected feedback through a built-in feature. Results Pilot testing of Rayyan focused on usability, accuracy against manual methods, and the added value of the prediction feature. The “taster” review (273 records) allowed a quick overview of Rayyan for early comments on usability. The second review (1030 records) required several iterations to identify the previously identified 11 trials. The “suggestions” and “hints,” based on the “prediction model,” appeared as testing progressed beyond five included studies. Post rollout user experiences and a reflexive response by the developers enabled real-time modifications and improvements. The survey respondents reported 40% average time savings when using Rayyan compared to others tools, with 34% of the respondents reporting more than 50% time savings. In addition, around 75% of the respondents mentioned that screening and labeling studies as well as collaborating on reviews to be the two most important features of Rayyan. As of November 2016, Rayyan users exceed 2000 from over 60 countries conducting hundreds of reviews totaling more than 1.6M citations. Feedback from users, obtained mostly through the app web site and a recent survey, has highlighted the ease in exploration of searches, the time saved, and simplicity in sharing and comparing include-exclude decisions. The strongest features of the app, identified and reported in user feedback, were its ability to help in screening and collaboration as well as the time savings it affords to users. Conclusions Rayyan is responsive and intuitive in use with significant potential to lighten the load of reviewers.
                Bookmark

                Author and article information

                Journal
                Turk J Emerg Med
                Turk J Emerg Med
                TJEM
                Turkish Journal of Emergency Medicine
                Wolters Kluwer - Medknow (India )
                2452-2473
                Oct-Dec 2021
                29 October 2021
                : 21
                : 4
                : 137-176
                Affiliations
                [1 ] Department of Emergency Medicine, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey
                [2 ] Department of Pulmonology, Dr. Suat Seren Chest Diseases and Chest Surgery Training and Research Hospital, University of Health Sciences, İzmir, Turkey
                [3 ] Department of Pulmonology, Faculty of Medicine, Gazi University, Ankara, Turkey
                [4 ] Department of Emergency Medicine, Dokuz Eylül University, İzmir, Turkey
                [5 ] Department of Pulmonology, Faculty of Medicine, Dokuz Eylül University, İzmir, Turkey
                [6 ] Department of Emergency Medicine, Keçiören Training and Research Hospital, University of Health Sciences, Ankara, Turkey
                [7 ] Department of Emergency Medicine, Ümraniye Training and Research Hospital, University of Health Sciences, İstanbul, Turkey
                [8 ] Department of Pulmonology, Near East University, Nicosia, TRNC
                [9 ] Department of Emergency Medicine, Faculty of Medicine, Marmara University, İstanbul, Turkey
                [10 ] Department of Biostatistics, Faculty of Medicine, Hacettepe University, Ankara, Turkey
                [11 ] Department of Pulmonology, Faculty of Medicine, Ankara University, Ankara, Turkey
                [12 ] Department of Pulmonology, Faculty of Medicine, Ege University, İzmir, Turkey
                [13 ] Department of Pulmonology, Faculty of Medicine, Aydın Adnan Menderes University, Aydın, Turkey
                Author notes
                Address for correspondence: Prof. Nurettin Özgür Doğan, Department of Emergency Medicine, Faculty of Medicine, Kocaeli University, Kocaeli, Turkey. E-mail: nurettinozgurdogan@ 123456gmail.com

                Author contribution statement

                Conceptualization (NOD, YV), data curation (NOD, YV, NK, EA, AÖA, ŞKÇ, GA, AB, HA, EŞ, BE, BB, SY, AG, MP), formal analysis-methodology (SK), resources (GA, ŞKÇ, HA), supervision (EA, AÖA, NK), writing (NOD, YV).

                Author information
                http://orcid.org/0000-0002-5209-8076
                http://orcid.org/0000-0003-4604-7173
                http://orcid.org/0000-0002-2889-7265
                http://orcid.org/0000-0002-3249-2420
                http://orcid.org/0000-0002-5711-1372
                http://orcid.org/0000-0001-7802-8087
                http://orcid.org/0000-0002-5580-3201
                http://orcid.org/0000-0002-9649-250X
                http://orcid.org/0000-0002-1316-0308
                http://orcid.org/0000-0002-8692-7266
                http://orcid.org/0000-0001-9656-131X
                http://orcid.org/0000-0003-2920-9214
                http://orcid.org/0000-0003-2084-2646
                http://orcid.org/0000-0003-1496-6976
                http://orcid.org/0000-0002-9321-6841
                http://orcid.org/0000-0001-7917-4297
                Article
                TJEM-21-137
                10.4103/2452-2473.329630
                8593424
                34849428
                7fcdfd6c-ff20-470f-a10c-f374ab661e38
                Copyright: © 2021 Turkish Journal of Emergency Medicine

                This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

                History
                : 30 September 2021
                : 08 October 2021
                : 09 October 2021
                Categories
                Clinical Guideline

                chronic obstructive pulmonary disease,dyspnea,emergency medicine,practice guideline (mesh database)

                Comments

                Comment on this article